Lung Cancer Publications | Research | IASLC

IASLC Publications

Download and read IASLC atlases, guides, periodicals and reports
authored by leading experts in lung cancer.


You are using an unlicensed and unsupported version of Evoq Content. Please contact your Systems Administrator for information on how to obtain a valid license.

CAP/IASLC/AMP Molecular Testing Guideline

The College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) have updated and revised their 2013 evidence-based guideline: "Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors."  

The "Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors" continues to set evidence-based standards for clinical molecular testing of non-small cell lung cancers (NSCLC) that effectively guides targeted therapy and treatment.

More Information

The IASLC Lung Cancer News

Published six times per year, the IASLC Lung Cancer News addresses the latest trends and news in the field.   

More Information   Download Latest Issue   VISIT THE OFFICIAL SITE